The global market for Next-Generation Immunology Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Next-Generation Immunology Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next-Generation Immunology Drugs by region & country, by Type, and by Application.

The Next-Generation Immunology Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Immunology Drugs.

Market Segmentation

Scope of Next-Generation Immunology Drugs - Market Report

Report Metric	Details
Report Name	Next-Generation Immunology Drugs - Market
CAGR	5%
Segment by Type:	Cell Therapy Small Molecule Drug Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next-Generation Immunology Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next-Generation Immunology Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next-Generation Immunology Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Next-Generation Immunology Drugs - Market report?

Ans: The main players in the Next-Generation Immunology Drugs - Market are Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company

What are the Application segmentation covered in the Next-Generation Immunology Drugs - Market report?

Ans: The Applications covered in the Next-Generation Immunology Drugs - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Next-Generation Immunology Drugs - Market report?

Ans: The Types covered in the Next-Generation Immunology Drugs - Market report are Cell Therapy, Small Molecule Drug, Others

1 Market Overview

1.1 Next-Generation Immunology Drugs Product Introduction

1.2 Global Next-Generation Immunology Drugs Market Size Forecast

1.3 Next-Generation Immunology Drugs Market Trends & Drivers

1.3.1 Next-Generation Immunology Drugs Industry Trends

1.3.2 Next-Generation Immunology Drugs Market Drivers & Opportunity

1.3.3 Next-Generation Immunology Drugs Market Challenges

1.3.4 Next-Generation Immunology Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Next-Generation Immunology Drugs Players Revenue Ranking (2023)

2.2 Global Next-Generation Immunology Drugs Revenue by Company (2019-2024)

2.3 Key Companies Next-Generation Immunology Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Next-Generation Immunology Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Next-Generation Immunology Drugs

2.6 Next-Generation Immunology Drugs Market Competitive Analysis

2.6.1 Next-Generation Immunology Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Next-Generation Immunology Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cell Therapy

3.1.2 Small Molecule Drug

3.1.3 Others

3.2 Global Next-Generation Immunology Drugs Sales Value by Type

3.2.1 Global Next-Generation Immunology Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Next-Generation Immunology Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Next-Generation Immunology Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Others

4.2 Global Next-Generation Immunology Drugs Sales Value by Application

4.2.1 Global Next-Generation Immunology Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Next-Generation Immunology Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Next-Generation Immunology Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Next-Generation Immunology Drugs Sales Value by Region

5.1.1 Global Next-Generation Immunology Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Next-Generation Immunology Drugs Sales Value by Region (2019-2024)

5.1.3 Global Next-Generation Immunology Drugs Sales Value by Region (2025-2030)

5.1.4 Global Next-Generation Immunology Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Next-Generation Immunology Drugs Sales Value, 2019-2030

5.2.2 North America Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Next-Generation Immunology Drugs Sales Value, 2019-2030

5.3.2 Europe Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Next-Generation Immunology Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Next-Generation Immunology Drugs Sales Value, 2019-2030

5.5.2 South America Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Next-Generation Immunology Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Next-Generation Immunology Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Next-Generation Immunology Drugs Sales Value

6.3 United States

6.3.1 United States Next-Generation Immunology Drugs Sales Value, 2019-2030

6.3.2 United States Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Next-Generation Immunology Drugs Sales Value, 2019-2030

6.4.2 Europe Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Next-Generation Immunology Drugs Sales Value, 2019-2030

6.5.2 China Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Next-Generation Immunology Drugs Sales Value, 2019-2030

6.6.2 Japan Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Next-Generation Immunology Drugs Sales Value, 2019-2030

6.7.2 South Korea Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Next-Generation Immunology Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Next-Generation Immunology Drugs Sales Value, 2019-2030

6.9.2 India Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Next-Generation Immunology Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer Inc

7.1.1 Pfizer Inc Profile

7.1.2 Pfizer Inc Main Business

7.1.3 Pfizer Inc Next-Generation Immunology Drugs Products, Services and Solutions

7.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 Pfizer Inc Recent Developments

7.2 Abbvie Inc.

7.2.1 Abbvie Inc. Profile

7.2.2 Abbvie Inc. Main Business

7.2.3 Abbvie Inc. Next-Generation Immunology Drugs Products, Services and Solutions

7.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Abbvie Inc. Recent Developments

7.3 Johnson and Johnson

7.3.1 Johnson and Johnson Profile

7.3.2 Johnson and Johnson Main Business

7.3.3 Johnson and Johnson Next-Generation Immunology Drugs Products, Services and Solutions

7.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 F. Hoffmann-La Roche Ltd. Recent Developments

7.4 F. Hoffmann-La Roche Ltd.

7.4.1 F. Hoffmann-La Roche Ltd. Profile

7.4.2 F. Hoffmann-La Roche Ltd. Main Business

7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Products, Services and Solutions

7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments

7.5 Amgen Inc.

7.5.1 Amgen Inc. Profile

7.5.2 Amgen Inc. Main Business

7.5.3 Amgen Inc. Next-Generation Immunology Drugs Products, Services and Solutions

7.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Amgen Inc. Recent Developments

7.6 Novartis AG

7.6.1 Novartis AG Profile

7.6.2 Novartis AG Main Business

7.6.3 Novartis AG Next-Generation Immunology Drugs Products, Services and Solutions

7.6.4 Novartis AG Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Novartis AG Recent Developments

7.7 Astellas Pharma Inc.

7.7.1 Astellas Pharma Inc. Profile

7.7.2 Astellas Pharma Inc. Main Business

7.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Products, Services and Solutions

7.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Astellas Pharma Inc. Recent Developments

7.8 Bristol-Myers Squibb Company

7.8.1 Bristol-Myers Squibb Company Profile

7.8.2 Bristol-Myers Squibb Company Main Business

7.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Products, Services and Solutions

7.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 Bristol-Myers Squibb Company Recent Developments

7.9 Merck & Co., Inc.

7.9.1 Merck & Co., Inc. Profile

7.9.2 Merck & Co., Inc. Main Business

7.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Products, Services and Solutions

7.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.9.5 Merck & Co., Inc. Recent Developments

7.10 Eli Lilly and Company

7.10.1 Eli Lilly and Company Profile

7.10.2 Eli Lilly and Company Main Business

7.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Products, Services and Solutions

7.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue (US$ Million) & (2019-2024)

7.10.5 Eli Lilly and Company Recent Developments

8 Industry Chain Analysis

8.1 Next-Generation Immunology Drugs Industrial Chain

8.2 Next-Generation Immunology Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Next-Generation Immunology Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Next-Generation Immunology Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

AbbVie

Johnson and Johnson

F Hoffmann La Roche Ltd

Amgen Inc

Novartis

Astellas Pharma Inc

Bristol Myers Squibb Company

Merck& Co. Inc

Eli Lilly and Company

List of Tables

Table 1. Next-Generation Immunology Drugs Market Trends

Table 2. Next-Generation Immunology Drugs Market Drivers & Opportunity

Table 3. Next-Generation Immunology Drugs Market Challenges

Table 4. Next-Generation Immunology Drugs Market Restraints

Table 5. Global Next-Generation Immunology Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Next-Generation Immunology Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Next-Generation Immunology Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Next-Generation Immunology Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Next-Generation Immunology Drugs

Table 10. Global Next-Generation Immunology Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Next-Generation Immunology Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Next-Generation Immunology Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Next-Generation Immunology Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Next-Generation Immunology Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Next-Generation Immunology Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Next-Generation Immunology Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Next-Generation Immunology Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Next-Generation Immunology Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Next-Generation Immunology Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Next-Generation Immunology Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Next-Generation Immunology Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Next-Generation Immunology Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Next-Generation Immunology Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Next-Generation Immunology Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Next-Generation Immunology Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Next-Generation Immunology Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Next-Generation Immunology Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Next-Generation Immunology Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. Pfizer Inc Basic Information List

Table 32. Pfizer Inc Description and Business Overview

Table 33. Pfizer Inc Next-Generation Immunology Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Pfizer Inc (2019-2024)

Table 35. Pfizer Inc Recent Developments

Table 36. Abbvie Inc. Basic Information List

Table 37. Abbvie Inc. Description and Business Overview

Table 38. Abbvie Inc. Next-Generation Immunology Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Abbvie Inc. (2019-2024)

Table 40. Abbvie Inc. Recent Developments

Table 41. Johnson and Johnson Basic Information List

Table 42. Johnson and Johnson Description and Business Overview

Table 43. Johnson and Johnson Next-Generation Immunology Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Johnson and Johnson (2019-2024)

Table 45. Johnson and Johnson Recent Developments

Table 46. F. Hoffmann-La Roche Ltd. Basic Information List

Table 47. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 48. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of F. Hoffmann-La Roche Ltd. (2019-2024)

Table 50. F. Hoffmann-La Roche Ltd. Recent Developments

Table 51. Amgen Inc. Basic Information List

Table 52. Amgen Inc. Description and Business Overview

Table 53. Amgen Inc. Next-Generation Immunology Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Amgen Inc. (2019-2024)

Table 55. Amgen Inc. Recent Developments

Table 56. Novartis AG Basic Information List

Table 57. Novartis AG Description and Business Overview

Table 58. Novartis AG Next-Generation Immunology Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Novartis AG (2019-2024)

Table 60. Novartis AG Recent Developments

Table 61. Astellas Pharma Inc. Basic Information List

Table 62. Astellas Pharma Inc. Description and Business Overview

Table 63. Astellas Pharma Inc. Next-Generation Immunology Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Astellas Pharma Inc. (2019-2024)

Table 65. Astellas Pharma Inc. Recent Developments

Table 66. Bristol-Myers Squibb Company Basic Information List

Table 67. Bristol-Myers Squibb Company Description and Business Overview

Table 68. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Bristol-Myers Squibb Company (2019-2024)

Table 70. Bristol-Myers Squibb Company Recent Developments

Table 71. Merck & Co., Inc. Basic Information List

Table 72. Merck & Co., Inc. Description and Business Overview

Table 73. Merck & Co., Inc. Next-Generation Immunology Drugs Products, Services and Solutions

Table 74. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Merck & Co., Inc. (2019-2024)

Table 75. Merck & Co., Inc. Recent Developments

Table 76. Eli Lilly and Company Basic Information List

Table 77. Eli Lilly and Company Description and Business Overview

Table 78. Eli Lilly and Company Next-Generation Immunology Drugs Products, Services and Solutions

Table 79. Revenue (US$ Million) in Next-Generation Immunology Drugs Business of Eli Lilly and Company (2019-2024)

Table 80. Eli Lilly and Company Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Next-Generation Immunology Drugs Downstream Customers

Table 84. Next-Generation Immunology Drugs Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Next-Generation Immunology Drugs Product Picture

Figure 2. Global Next-Generation Immunology Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Next-Generation Immunology Drugs Report Years Considered

Figure 5. Global Next-Generation Immunology Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next-Generation Immunology Drugs Revenue in 2023

Figure 7. Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Cell Therapy Picture

Figure 9. Small Molecule Drug Picture

Figure 10. Others Picture

Figure 11. Global Next-Generation Immunology Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Next-Generation Immunology Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospital

Figure 14. Product Picture of Clinic

Figure 15. Product Picture of Others

Figure 16. Global Next-Generation Immunology Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Next-Generation Immunology Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Next-Generation Immunology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Next-Generation Immunology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Next-Generation Immunology Drugs Sales Value (%), (2019-2030)

Figure 29. United States Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 35. China Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 37. China Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. India Next-Generation Immunology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Next-Generation Immunology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. India Next-Generation Immunology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. Next-Generation Immunology Drugs Industrial Chain

Figure 51. Next-Generation Immunology Drugs Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17Q10023

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8U10163

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11I9951

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34H832

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Next-Generation Immunology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-16B14214

Next-Generation Immunology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Next-Generation Immunology Drugs - Market Size

Next-Generation Immunology Drugs - Market

Report Scope

Scope of Next-Generation Immunology Drugs - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Next-Generation Immunology Drugs - Market report?

What are the Application segmentation covered in the Next-Generation Immunology Drugs - Market report?

What are the Type segmentation covered in the Next-Generation Immunology Drugs - Market report?

FEATURED COMPANIES

RELATED REPORTS